256
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

TARC and Septin 7 can be better monitoring biomarkers than CX3CL1, sICAM5, and IRF5 in children with seizure-free epilepsy with monotherapy and drug-resistant epilepsy

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 243-252 | Received 28 Dec 2021, Accepted 23 Jun 2022, Published online: 10 Aug 2022

References

  • Fisher RS, Boas WVE, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the ınternational league Against epilepsy (ILAE) and the ınternational bureau for epilepsy (IBE). Epilepsia. 2005;46(4):470–472.
  • Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Wiley Online Library; 2010.
  • Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol. 2009;5(7):380–391.
  • Alyu F, Dikmen M. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms. Acta Neuropsychiatr. 2017;29(1):1–16.
  • Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia. 2005;46(11):1724–1743.
  • Maroso M, Balosso S, Ravizza T, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med. 2010;16(4):413–419.
  • Ichiyama T, Nishikawa M, Yoshitomi T, et al. Tumor necrosis factor-a, interleukin-lβ, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures comparison with acute encephalitis/encephalopathy. Neurology. 1998;50(2):407–411.
  • Plata-Salamán CR, Ilyin SE, Turrin NP, et al. Kindling modulates the IL-1β system, TNF-α, TGF-β1, and neuropeptide mRNAs in specific brain regions. Brain Res Mol Brain Res. 2000;75(2):248–258.
  • Han T, Qin Y, Mou C, et al. Seizure induced synaptic plasticity alteration in hippocampus is mediated by IL-1β receptor through PI3K/Akt pathway. Am J Transl Res. 2016;8(10):4499–4509.
  • Tian L, Lappalainen J, Autero M, et al. Shedded neuronal ICAM-5 suppresses T-cell activation. Blood J Am Soc Hematol. 2008;111(7):3615–3625.
  • Yoshihara Y, Mori K. Telencephalin: a neuronal area code molecule? Neurosci Res. 1994;21(2):119–124.
  • Annaert WG, Esselens C, Baert V, et al. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron. 2001;32(4):579–589.
  • Guo H, Tong N, Turner T, et al. Release of the neuronal glycoprotein ICAM-5 in serum after hypoxic-ischemic injury. Ann Neurol. 2000;48(4):590–602.
  • Rieckmann P, Turner T, Kilgannon P, et al. Telencephalin as an indicator for temporal-lobe dysfunction. The Lancet. 1998;352(9125):370–371.
  • Yuan L, Wei F, Zhang X, et al. Intercellular adhesion molecular-5 as marker in HIV associated neurocognitive disorder. Aging Dis. 2017;8(3):250.
  • Maciejewski-Lenoir D, Chen S, Feng L, et al. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J Immunol. 1999;163(3):1628–1635.
  • Roseti C, Fucile S, Lauro C, et al. Fractalkine/CX 3 CL 1 modulates GABA A currents in human temporal lobe epilepsy. Epilepsia. 2013;54(10):1834–1844.
  • Liu W, Jiang L, Bian C, et al. Role of CX3CL1 in diseases. Arch Immunol Ther Exp (Warsz). 2016;64(5):371–383.
  • Yanai H, Chen H-m, Inuzuka T, et al. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci U S A. 2007;104(9):3402–3407.
  • Barnes BJ, Moore PA, Pitha PM. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon α genes. J Biol Chem. 2001;276(26):23382–23390.
  • Takaoka A, Yanai H, Kondo S, et al. Integral role of IRF-5 in the gene induction programme activated by toll-like receptors. Nature. 2005;434(7030):243–249.
  • Al Mamun A, Chauhan A, Qi S, et al. Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes. Proc Natl Acad Sci U S A. 2020;117(3):1742–1752.
  • Takegawa S, Jin Z, Nakayama T, et al. Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related epstein–barr virus-associated B-cell lymphoproliferative disorder. Cancer Sci. 2008;99(2):296–302.
  • Lacy P. Eosinophil cytokines in allergy. In: Cytokine effector functions in tissues.: Elsevier; 2017. p. 173–218.
  • Niens M, Visser L, Nolte IM, et al. Serum chemokine levels in hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22. Br J Haematol. 2008;140(5):527–536.
  • Kakinuma T, Nakamura K, Wakugawa M, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol. 2001;107(3):535–541.
  • Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci. 2006;43(2):75–84.
  • Pollard JR, Eidelman O, Mueller GP, et al. The TARC/sICAM5 ratio in patient plasma is a candidate biomarker for drug resistant epilepsy. Front Neurol. 2012;3:181.
  • Wang X, Fei F, Qu J, et al. The role of septin 7 in physiology and pathological disease: a systematic review of current status. J Cell Mol Med. 2018;22(7):3298–3307.
  • LobatoMárquez D, Krokowski S, Sirianni A -, et al. Requirement for septins and the autophagy receptor p62 in the proliferation of intracellular shigella. Cytoskeleton (Hoboken). 2019;76(1):163–172.
  • Phan QT, Eng DK, Mostowy S, et al. Role of endothelial cell septin 7 in the endocytosis of Candida albicans. MBio. 2013;4(6):e00542-13–e00513.
  • Pfanzelter J, Mostowy S, Way M. Septins suppress the release of vaccinia virus from infected cells. J Cell Biol. 2018;217(8):2911–2929.
  • Degroote RL, Hauck SM, Amann B, et al. Unraveling the equine lymphocyte proteome: differential septin 7 expression associates with immune cells in equine recurrent uveitis. PLoS One. 2014;9(3):e91684.
  • Engmann O, Hortobagyi T, Pidsley R, et al. Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. Brain. 2011;134(Pt 8):2408–2421.
  • Tada T, Simonetta A, Batterton M, et al. Role of septin cytoskeleton in spine morphogenesis and dendrite development in neurons. Curr Biol. 2007;17(20):1752–1758.
  • CANGÜR Ş S, MA AH. The methods used in nonparametric covariance analysis. Duzce Med J. 2018;20(1):1–6.
  • Engmann O, Hortobágyi T, Thompson AJ, et al. Cyclin-dependent kinase 5 activator p25 is generated during memory formation and is reduced at an early stage in alzheimer’s disease. Biol Psychiatry. 2011;70(2):159–168.
  • Yadav S, Oses-Prieto JA, Peters CJ, et al. TAOK2 kinase mediates PSD95 stability and dendritic spine maturation through Septin7 phosphorylation. Neuron. 2017;93(2):379–393.
  • Xie Y, Vessey JP, Konecna A, et al. The GTP-binding protein septin 7 is critical for dendrite branching and dendritic-spine morphology. Curr Biol. 2007;17(20):1746–1751.
  • Hawasli AH, Benavides DR, Nguyen C, et al. Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat Neurosci. 2007;10(7):880–886.
  • Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000;57(1):65–73.
  • Kolomeets NS, Orlovskaya DD, Rachmanova VI, et al. Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse. 2005;57(1):47–55.
  • Lefranc D, Launay D, Dubucquoi S, et al. Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. Arthritis Rheum. 2007;56(10):3420–3432.
  • Multani P, Myers R, Blume H, et al. Neocortical dendritic pathology in human partial epilepsy: a quantitative golgi study. Epilepsia. 1994;35(4):728–736.
  • Johnston D, Magee JC, Colbert CM, et al. Active properties of neuronal dendrites. Annu Rev Neurosci. 1996;19(1):165–186.
  • Abegg MH, Savic N, Ehrengruber MU, et al. Epileptiform activity in rat hippocampus strengthens excitatory synapses. J Physiol. 2004;554(Pt 2):439–448.
  • Hu B, Karnup S, Zhou L, et al. Reversal of hippocampal LTP by spontaneous seizure-like activity: role of group I mGluR and cell depolarization. J Neurophysiol. 2005;93(1):316–336.
  • Kastenbauer S, Koedel U, Wick M, et al. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. J Neuroimmunol. 2003;137(1-2):210–217.
  • Nishiyori A, Minami M, Ohtani Y, et al. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett. 1998;429(2):167–172.
  • Limatola C, Lauro C, Catalano M, et al. Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J Neuroimmunol. 2005;166(1-2):19–28.
  • Ragozzino D, Di Angelantonio S, Trettel F, et al. Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J Neurosci. 2006;26(41):10488–10498.
  • Sheridan GK, Wdowicz A, Pickering M, et al. CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity. Front Cell Neurosci. 2014;8:233.
  • Xu Y, Zeng K, Han Y, et al. Altered expression of CX3CL1 in patients with epilepsy and in a rat model. Am J Pathol. 2012;180(5):1950–1962.
  • Fan Z, Zhao S, Zhu Y, et al. Interferon regulatory factor 5 mediates Lipopolysaccharide-Induced neuroinflammation. Front Immunol. 2020;11:600479.
  • Balosso S, Maroso M, Sanchez-Alavez M, et al. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1β. Brain. 2008;131(Pt 12):3256–3265.
  • Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol. 2012;33(1):116–125.
  • Imai T, Baba M, Nishimura M, et al. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997;272(23):15036–15042.
  • Lindsberg PJ, Launes J, Tian L, et al. Release of soluble ICAM-5, a neuronal adhesion molecule, in acute encephalitis. Neurology. 2002;58(3):446–451.
  • Tian L, Kilgannon P, Yoshihara Y, et al. Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18. Eur J Immunol. 2000;30(3):810–818.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.